{"nct_id":"NCT03837899","title":"Durvalumab and Tremelimumab for Pediatric Malignancies","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2024-10","start_date":"2019-03-07","start_date_type":"ACTUAL","primary_completion_date":"2023-02-28","primary_completion_date_type":"ACTUAL","completion_date":"2024-12-30","completion_date_type":"ESTIMATED","phases":["PHASE1","PHASE2"],"tickers":["AZN"]}